EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Neoadjuvant chemotherapy with or without anthracyclines in combination with single HER2-targeted therapy in HER2-positive breast cancer

Anshul Gupta, Ajay Gogia, Svs Deo, D N Sharma, Sandip Mathur, Hari Krishna Raju Sagiraju

Cancer Treatment and Research Communications · 2023

DOI: 10.1016/j.ctarc.2023.100741 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Treatment and Research Communications, 2023. Verfasst von Anshul Gupta und 5 weiteren Autor:innen. Beteiligte Einrichtung: All India Institute of Medical Sciences (AIIMS), New Delhi, India. Hauptthemen laut MEDLINE: Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: All-India Institute of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHumansFemaleDocetaxelAnthracyclinesNeoadjuvant TherapyRetrospective StudiesAntibodies, Monoclonal, HumanizedTaxoidsTrastuzumab

Stichwörter der Autor:innen

AnthracyclinesHER2-positive breast cancerNeoadjuvant chemotherapyTrastuzumabpCR

Substanzen

DocetaxelAnthracyclinesAntibodies, Monoclonal, HumanizedTaxoidsTrastuzumab

Autor:innen und Institutionen

  • All India Institute of Medical Sciences (AIIMS), New Delhi, India.
  • All India Institute of Medical Sciences (AIIMS), New Delhi, India. Electronic address: ajaygogia@gmail.com.
  • National Cancer Institute, Jhajjar, Haryana, India.

Förderung

  • All-India Institute of Medical Sciences

Zitieren

APA

Gupta, A., Gogia, A., Deo, S., Sharma, D. N., Mathur, S., & Sagiraju, H. K. R. (2023). Neoadjuvant chemotherapy with or without anthracyclines in combination with single HER2-targeted therapy in HER2-positive breast cancer. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2023.100741

Vancouver

Gupta A, Gogia A, Deo S, Sharma DN, Mathur S, Sagiraju HKR. Neoadjuvant chemotherapy with or without anthracyclines in combination with single HER2-targeted therapy in HER2-positive breast cancer. Cancer Treatment and Research Communications. 2023. doi:10.1016/j.ctarc.2023.100741

BibTeX
@article{Gupta2023,
  author = {Gupta, Anshul and Gogia, Ajay and Deo, Svs and Sharma, D N and Mathur, Sandip and Sagiraju, Hari Krishna Raju},
  title = {Neoadjuvant chemotherapy with or without anthracyclines in combination with single HER2-targeted therapy in HER2-positive breast cancer},
  journal = {Cancer Treatment and Research Communications},
  year = {2023},
  doi = {10.1016/j.ctarc.2023.100741}
}
Kostenlos starten →